SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: February 28, 1998
Commission File Number: 0-16035
SONO-TEK CORPORATION
(Exact name of Registrant as Specified in its Charter)
NEW YORK 14-1568099
(State or other Jurisdiction of (IRS Employer Identification Number)
Incorporation or Organization)
2012 Route 9W, Bldg. 3, Milton, New York 12547
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code: (914) 795-2020
Securities Registered Pursuant to Section 12(b) of the Act: None
Securities Registered Pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
(Title of Class)
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. X Yes __ No
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]
As of May 20, 1998 the aggregate market value of the Registrant's Common
Stock held by non-affiliates of the Registrant was approximately $2,597,000
computed by reference to the average of the bid and asked prices of the Common
Stock on said date, which average was $0.69.
The Registrant had 4,374,387 shares of Common Stock outstanding as of May
20, 1998.
Documents incorporated by reference: Registrant's definitive Proxy
Statement to be filed for 1998 Annual Meeting (Part III, Items 11-13)
<PAGE>
PART I
------
ITEM 1 Business
- - ------
(a) General Development of Business.
--------------------------------
Sono-Tek Corporation (the "Company" or "Sono-Tek") was incorporated in New York
on March 21, 1975 for the purpose of engaging in the development, manufacture,
and sale of ultrasonic liquid atomizing units consisting of (i) a nozzle based
on patented technology, and (ii) an electrical power supply and related hardware
(the "Nozzle Systems"). Nozzle Systems atomize low-to-medium viscosity liquids
used in laboratory and industrial spray processes by converting electrical
energy into mechanical motion in the form of high-frequency (ultrasonic)
vibrations which break liquids into minute drops that can be applied to surfaces
at low-velocity.
Throughout the fiscal year ended February 28, 1998 ("Fiscal 1998"), the Company
continued production and sales of its established line of Nozzle Systems. The
Company is continuously striving to improve the performance and versatility of
its Nozzle Systems, as well as searching for new industry applications.
During Fiscal 1990, the Company initiated the development of the SonoFlux System
which applies a uniform coating of flux to printed circuit boards immediately
prior to the components being soldered in place. This system was the first
product of the Company that incorporates its basic Nozzle System technology into
an end-user ready machine which can be targeted for a very specific and
identifiable market segment, the electronic circuit board assembly industry.
After an initial period of marketing and customer evaluation during Fiscal 1991,
the Company realized its initial sales during Fiscal 1992.
In Fiscal 1995, the Company introduced the latest generation of this product,
the SonoFlux 9500. This new generation of machines was designed to enable
Sono-Tek to participate in all segments of the spray fluxing market. For
prospective customers where price is the most important factor in making a
purchase decision, the entry level model of the 9500 is priced 25% lower than
the previous SonoFlux System. For that segment of the market where full factory
automation is a must, the high-end model of the SonoFlux 9500 is fully automated
and computer controlled, and is priced to compete favorably against other
products in the market. The 9500, in addition to being designed to satisfy the
demands of the market, is significantly easier to manufacture than its
predecessor, and takes advantage of "off-the-shelf" components wherever possible
to reduce the need for custom designed and manufactured parts. The overall
performance, reliability, and ease of use of this system has been complimented
by many customers.
During Fiscal 1998, the Company developed several new products. A complete
family of liquid delivery products including a Gravity Feed System, a Syringe
Pump, and multiple models of Gear Pumps and Pressure Reservoirs are intended to
enable customers to purchase a complete, fully integrated and tested spray
solution from a single supplier. The new Sono-Tek MCS Infinity System is a
precise, highly efficient spray coating system designed for general top-down
spraying applications, while the Accu-Mist System provides the ability to spray
liquids to very small areas, either as discrete dots or continuous lines.
(b) Financial Information about Industry Segments.
----------------------------------------------
The Company is engaged in one industry segment and line of business.
(c) Description of Business.
------------------------
Background
- - ----------
The Company is engaged in the development, manufacture, and sale of ultrasonic
liquid atomizing units consisting of a nozzle based on patented technology and
an electrical power supply unit and related hardware that atomizes low-to-medium
viscosity liquids used in industrial spraying applications.
Nozzle Systems operate on a different principle from that employed in
conventional nozzles, such as compressed gas or hydraulic nozzles ("Conventional
Nozzles"), or in other coating methods such as fill and aspiration (when a
container is filled with a substance and the excess is removed by various
methods) or batch dipping.
Nozzle Systems break the liquid stream into a spray of minute drops by intense
ultrasonic vibrations concentrated on the head of the nozzle, called the
"atomizing surface". The spray pattern depends on the shape of the atomizing
surface. The Company manufactures nozzles with atomizing surfaces that produce
spray shapes to meet individual customer specifications. In addition, nozzles
are made in different sizes and configurations to accommodate various flow rates
and to meet other requirements with respect to specific applications.
Nozzle Systems produce a soft low-velocity spray of liquid which results in
minimal waste or loss to the surrounding environment. Conventional Nozzles tend
to deliver a hard, high-velocity spray. When applying spray coatings to surfaces
using pressure nozzles, much of the often expensive and/or hazardous material
bounces off the surface and is lost into the environment. This so-called
"overspraying" not only represents increased cost to the user, but is also a
source of environmental pollution. Sono-Tek's Nozzle Systems, due to the soft
nature of the spray produced, virtually eliminate such overspray. In addition,
the Nozzle Systems are capable of spraying material in minute amounts on the
order of one-millionth of a liter of liquid per second, and are capable of
delivering material without introducing gas into an industrial process as do
compressed gas nozzles.
Ultrasonic nozzles typically have larger passageways than Conventional Nozzles
spraying material at similar flow rates, which the Company believes makes
ultrasonic nozzles more resistant to clogging than Conventional Nozzles.
Marketing Overview
- - ------------------
The SonoFlux System accounted for approximately 76% of the Company's sales
during Fiscal 1998, 66% during Fiscal 1997, and 63% during Fiscal 1996. Nozzle
Systems accounted for 21%, 34% and 37%, during those same years, respectively.
During Fiscal 1998, sales of the new MCS Infinity System accounted for 3% of the
Company's sales. No single customer accounted for more than 10% of net sales in
Fiscal 1998, 1997 and 1996.
The sales function of the Company is currently performed by four people located
in the Company's facilities in Milton, New York. This organization consists of a
National Sales Manager, two Regional Sales Managers, and an Administrative
Assistant.
The primary marketing and sales of the Company's Nozzle Systems is through its
own direct sales force. A majority of sales leads are generated via direct mail
advertising, advertisements and technical articles in trade journals, new
product releases, participation in trade shows and seminars, and by responses to
the Company's home page on the Internet.
The Company markets Nozzle Systems to customers requiring specialized
applications of liquids to their products. To date, the Company's sales have
been made to end users who use Nozzle Systems in the manufacture of their own
products, to original equipment manufacturers ("OEMs") who incorporate Nozzle
Systems into their own products for resale, and to government, university and
private laboratories who use Nozzle Systems for research projects.
In January, 1998, the Company signed a Distribution Agreement with a European
company which develops, manufactures, and sells hydraulic nozzles and associated
products. Under the terms of this Agreement, this company and its subsidiaries
in eleven countries covering parts of Europe, Asia and South America, will sell
Nozzle Systems, Liquid Delivery Systems, Broadband Ultrasonic Generators, Accu-
Mist Systems, MCS Infinity Systems, and all accessories. There were no sales
made through this company in Fiscal 1998.
The market for the SonoFlux product line is the Printed Circuit Board (PCB)
assembly industry. A majority of sales leads are generated via advertisements
and technical articles in trade journals, new product releases, direct mailings
and participation in trade shows and seminars. For this product line, the
Company utilizes the services of independent Manufacturer's Representatives
("Reps") in North America to augment its internal direct sales force. These Rep
organizations are paid a commission on sales after the Company receives payment
from the customer. The Company currently has thirteen such Rep organizations
under contract with a total of approximately forty individuals performing direct
sales.
To increase the Company's presence in foreign markets, the Company uses
Distributors to market the SonoFlux product line in certain European and Far
Eastern countries. The Company currently has thirteen such Distributor companies
under contract.
Initial sales of a new MCS Infinity System were made during Fiscal 1998 to
companies for general top-down spraying applications. This new product consists
of (i) a Control Module which provides power to the Ultrasonic Nozzle, liquid
delivery, and electronic control and interface functions, (ii) an Ultrasonic
Nozzle, and (iii) a Vertical Jet Assembly which is available in a wide variety
of designs to accommodate various spray widths. Each module is capable of
spraying areas as narrow as 0.25 inches or as wide as one foot. Areas greater
than one foot in width can be accommodated by grouping together as many
individual modules as necessary. The Company anticipates this product will
satisfy the requirements of a broad range of industrial applications.
Markets for the Company's Products
- - ----------------------------------
Nozzle Systems
The Company markets Nozzle Systems to customers requiring specialized
applications of liquids to their products. Manufacturers of medical devices use
the Nozzle Systems to uniformly coat portions of their products with specific
quantities of biochemical compounds. Semiconductor manufacturers use Nozzle
Systems to apply chemicals on silicon wafers in the production of integrated
circuits. Nozzle Systems are sold for a variety of other applications including
spray drying of ceramics, lubrication, moisturization, and application of
protective coatings to float glass.
The Company works with potential customers in industries which it believes can
benefit from Nozzle Systems to meet specialized application requirements. The
Company has been concentrating its efforts on establishing its presence in a
number of different markets. (See "Product Development"). Currently, the
Company's principal markets for its products are in the medical products,
semiconductor manufacturing and electronics fabrication industries.
SonoFlux System
The SonoFlux System is attractive to the electronics industry because it
significantly reduces the amount of flux consumed, the related emission of these
materials to the environment, and the cost of disposing of waste flux.
MCS Infinity System
The initial shipment of the Sono-Tek's MCS Infinity System occurred during
Fiscal 1998 to companies using them to apply liquids to various widths of
material on the top side of surfaces.
Product Development
For the Fiscal years ended February 28, 1998, February 28, 1997, and February
29, 1996, the Company expended approximately $410,000, $369,000, and $380,000,
respectively on research and development costs. In addition to continuous
improvement programs on Nozzle Systems and the SonoFlux 9500, these expenditures
were incurred to develop (i) a photoresist application system for the
semiconductor industry, (ii) the Accu-Mist System, (iii) a range of liquid
delivery systems including a Gravity feed System, a Syringe Pump, and multiple
models of Gear Pumps and Pressure Reservoirs, and (iv) the MCS Infinity System.
Management believes that the Company's long-term growth and stability is linked
to the continuous development and release of products that provide total
solutions to customer needs across a wide spectrum of industries, and advance
the utility of the Company's basic technology.
Nozzle Products
During the third quarter of Fiscal 1997, the Company introduced new power
supply, the Broadband Ultrasonic Generator, or the "BUG". This power supply
provides a stable, frequency-locked electrical signal to the attached ultrasonic
nozzle and is capable of driving all of the Company's nozzles.
SonoFlux System
The SonoFlux 9500 is based on the industry proven design utilizing Sono-Tek's
patented spray assembly with a stationary ultrasonic nozzle and spray dispersion
mechanism. This well- established technology has been combined with a flexible
programmable logic controller to monitor and control all system functions. Any
system parameter is easily changed using an operator keypad and LCD display. The
controller also provides visual and audible warnings for system errors and
alarms.
The unit can be programmed by a user friendly Windows program from a personal
computer and has the capacity to store up to 250 customized programs.
Several SonoFlux 9500 models are available including units for retrofit inside
wave soldering machines, stand alone units for assembly around existing finger
or pallet conveyors, stand alone units complete with integral chain/tab
conveyors and configurations capable of operating in an inert environment.
During Fiscal 1997, the SonoFlux System was tested and certified by an
independent testing laboratory. The system passed all of the safety and other
tests required to be "CE" compliant which is a prerequisite to sell into the
European market.
Accu-Mist System
The continuing growth of surface mount technology in the electronic assembly
industry has created a need for an effective method of applying liquid solder
flux only to selected portions of a PCB assembly. This technique is referred to
as selective soldering. In addition to applying flux selectively to PCB
assemblies, there are other applications that can benefit from this technique.
These include ball-grid arrays, flip-chips, and a variety of tape-and-reel
configurations.
The Company recognized the need to target the emerging industry application for
selective soldering, and in February 1997, announced the Accu-Mist System to
address this need. The Accu-Mist incorporates an ultrasonic nozzle designed for
low flow rates, together with a spray-shaping device to gently shape the spray
from the nozzle into a precisely defined pattern whose width can be adjusted
from 0.070 to 0.250 inches. Other attractive features of this system is that it
is a non-contact process, and because of its low-energy nature, fragile
components are completely shielded from any disturbance due to the spray.
The nozzle and spray shaping device can be mounted on any type of robotic arm,
conveyor, or X-Y table. Patterns of virtually any shape can be produced. For
example, discrete dots, containing only a few-tenths of a microliter of flux or
continuous patterns, such as lines, can be deposited.
MCS Infinity System
The Sono-Tek MCS Infinity System is a precise, highly efficient spray coating
system designed for general top-down spraying applications. This new product
consists of (i) a Control Module which provides power to the Ultrasonic Nozzle,
liquid delivery, and electronic control and interface functions, (ii) an
Ultrasonic Nozzle, and (iii) a Vertical Jet Assembly which is available in a
wide variety of designs to accommodate various spray widths. Each module is
capable of spraying areas as narrow as 0.25 inches or as wide as one foot. Areas
greater than one foot in width can be accommodated by grouping together as many
individual modules as necessary. This versatile, modular system delivers a soft,
uniform and highly controllable spray over any substrate width. These standard
modules are then custom configured for each user's application with custom
hardware and interface electronics.
Liquid Delivery Systems
During Fiscal 1998, Sono-Tek announced a family of liquid delivery systems.
These new products are intended to enable customers to purchase a complete,
fully integrated and tested spray solution from a single supplier. The liquid
delivery systems fall into four basic categories.
1. Syringe Pumps are the most precise of all liquid delivery methods, and are
ideal for very low flow rates, including single shots down to the nanoliter
range.
2. Gear Type Metering Pumps are characterized by their capability to meter the
flow of liquid accurately over a wide range of flow rates without
pulsation. Two models are available to accommodate various flow ranges.
3. Pressurized Reservoir Systems provide a highly reliable, yet cost effective
approach for use in the most demanding applications, especially where the
liquid contains undissolved solids or abrasive materials. Several models
are available, ranging from 6 ounces to 3 gallon reservoir capacities, and
can be used for either continuous flow or single-shot dispensing.
4. Gravity Operated Systems are a low cost, versatile solution for use
primarily in laboratory applications or for feasibility testing.
The Company manufactures the nozzles for the liquid delivery systems. The pumps
and related parts are purchased from outside suppliers, and assembled at the
Company.
Manufacturing
- - -------------
The Company currently employs twelve persons for its manufacturing and quality
control activities. The Company's manufacturing operations are located in one
facility in the town of Milton, New York. The Company is fully utilizing this
facility. Based on the success of the Company's new product announcements, the
Company may need to increase the size of its facility. Space of the type and
size required by the Company is readily available in the area at competitive
prices.
The Company's current manufacturing area consists of (i) a machine shop, (ii) a
nozzle assembly/test area, (iii) an electronics assembly area, (iv) a system
assembly area, and (v) a receiving and shipping area. The machine shop produces
machined parts for nozzle systems, components for development projects and
custom parts to satisfy unique customer requirements. During the fourth quarter
of Fiscal 1998, the Company purchased new production equipment which management
believes will reduce production costs and improve quality. It is believed that
all of these services could be obtained at numerous local machine shops if
required.
The nozzle assembly and test area assembles the machined components of the
nozzle with purchased crystals and electrodes, and after a visual inspection and
aging period, subjects the nozzle to test procedures to assess its performance
characteristics. In the electronics assembly area, assembled electronic circuit
boards, pumps, and power supplies are mounted in sheet metal enclosures and
suitably wired to provide interconnections between the individual components and
sub-assemblies. The circuit boards and the components that populate them, as
well as the sheet metal components, are purchased from outside suppliers and are
available from a wide range of suppliers throughout the world.
The System assembly area combines the assembled modules from the electronics
assembly area, the assembled and tested ultrasonic nozzle, and additional sheet
metal and wiring to complete SonoFlux systems, MCS Infinity Systems, Liquid
Delivery Systems, and Accu-Mist Systems.
Other parts, including pumps used in the Nozzle Systems or the SonoFlux System
are purchased as finished units from various suppliers. All raw materials used
in the Company's products are readily available from many different domestic
suppliers.
The Company provides a limited warranty on all of its products covering parts
and labor for a period of one year from the date of sale.
The Company maintains comprehensive general liability insurance in an amount
which it believes is adequate for the nature of its operations.
As part of its strategic plan for Fiscal 1998, the Company initiated a program
to become ISO 9001 Registered. Management believes that achieving this standard
demonstrates a long-term commitment to the business and will provide a
competitive edge in marketing. In addition to the high degree of quality implied
by being ISO registered, the Company expects that such registration will
discipline the Company in running its business and will stimulate continuous
improvement. This program is nearing completion, and management expects the
Company will become ISO 9001 Registered during Fiscal 1999.
Patents
- - -------
The Company's present and proposed business is based in part on the technology
covered by eight United States patents held by the Company. Patent applications,
based on the United States applications, covering fundamental aspects of the
ultrasonic technology developed by the Company have been issued or are pending
in several foreign jurisdictions. Such patents expire during the period of
November 1998 through December 2007. The Company's earliest patent on its
central-bolt nozzle design, used in current product offerings, is due to expire
in October 1999. The Company has been granted a patent on the spray assembly
portion of its SonoFlux System, which will expire in June, 2010. There can be no
assurance that the Company's existing patents will, if challenged, be upheld, or
that any such patents will afford the necessary degree of patent protection with
respect to the Nozzle Systems. Furthermore, due to the high cost of maintaining
patents in several foreign jurisdictions, the Company determined not to maintain
its patent protection in certain countries in which the Company believes the
protection is no longer required. During the Fiscal years ended February 29,
1996 and February 28, 1995 the Company abandoned certain patents it held in
foreign countries. The book value of such patents was approximately $13,000 and
$27,000, respectively. There can be no assurance that events will not occur
which, as a result of the Company's failure to maintain its patent protection,
would have a material adverse affect on the Company's sales in such foreign
jurisdictions.
In addition, the Company may be unable, for financial or other reasons, to
enforce its rights under its patents. The Company also relies on unpatented
know-how in the production of its Nozzle Systems. Management is aware of one
other company that has developed a nozzle that operates in a manner similar to
the nozzle that is part of the Company's Nozzle Systems. This company has access
to significant financial resources. There can be no assurance, however, that
this company will not develop additional nozzle designs and thus expand the
applications of its nozzles. Moreover, technological advances have evolved in
the nozzle industry and there can be no assurance that these companies or other
entities with far greater resources and capabilities than the Company will not
develop products competitive with the Company's Nozzle System. (See
"Competition").
Competition
- - -----------
Nozzle Systems are sold primarily to customers that require specific performance
characteristics which the Company believes are not attainable using competing
methods, such as Conventional Nozzles or other coating methods. At present,
management is aware of only one other company that manufactures nozzles that
operate in a manner similar to the nozzle that is part of the Company's Nozzle
Systems. This company possesses significant financial resources. (See
"Patents"). There can be no assurance, however, that other manufacturers,
including well-established companies that have substantially greater financial
and other resources than the Company, will not seek to compete with the Company
in producing specialized nozzles in the future. If such companies decide to
enter into the specialized nozzle business, there can be no assurance that the
Company will be able to successfully compete with them.
In the electronic fabrication area, the Company's SonoFlux System competes with
several other companies. Although management believes that it has competed
against such companies successfully in the past, there can be no assurance that
these results will continue. In addition, there can be no assurance that other
companies, including well-established companies that have substantially greater
financial and other resources than the Company, will not seek to compete with
the Company in the electronic assembly industry or that the Company will be able
to compete successfully with them if such companies decide to enter into that
business.
Employees
- - ---------
As of May 20, 1998, the Company had 28 full-time employees. The Company believes
that its relationship with its employees is good.
(d) Financial Information about Foreign and Domestic Operations and Export
---------------------------------------------------------------------------
Sales
-----
During Fiscal 1997 and 1996, the Company reduced its selling efforts in the
European and Far East markets and focused on the North American market. As a
result, sales to foreign customers accounted for approximately $435,000 or 12%
of total revenue in Fiscal 1998, $679,000 or 22% in Fiscal 1997 and $744,000 or
27% in Fiscal 1996.
In addition to in-house resources, the Company utilizes independent sales
representatives or sales representative companies throughout North America
(including parts of Canada and Mexico) to sell SonoFlux equipment on a
commission basis and continued to do so through Fiscal 1998.
(e) Backlog
-------
The backlog for the Company's products was approximately $104,000, $81,000 and
$150,000 as of February 28, 1998, 1997 and 1996, respectively. The Company
anticipates that it will ship all of its February 28, 1998 backlog during Fiscal
1999.
ITEM 2 Properties
- - ------
The Company's office, product development, manufacturing and assembly facilities
are located in one building consisting of 13,200 square feet of space at 2012
Route 9W, Building 3, Milton, New York. The Company leased these facilities
pursuant to a lease which expired January 31, 1997. The Company had an option at
the end of the lease term to renew the lease for an additional five year period,
but that option was not exercised. As of May 20, 1998 the Company has not signed
a renewal lease agreement. The Company is making payments on a month-to-month
basis equal to the amount that would have been required per month if the option
had been exercised. Based on the success of the Company's new product
announcements, the Company may need to increase the size of its facility.
Management believes that space of the type and size required by the Company is
readily available in the area at competitive prices.
ITEM 3 Legal Proceedings
- - ------
None
ITEM 4 Submission of Matters to a Vote of Security Holders
- - ------
None
PART II
-------
ITEM 5 Market for Registrant's Common Equity and Related Stockholder Matters
- - ------
(a) The Company's Common Stock trades in the over-the-counter market on the OTC
Bulletin Board. The following table sets forth the range of high and low
closing bid quotations for the Company's Common Stock for the periods
indicated as furnished by the National Quotations Bureau, Incorporated.
<TABLE>
<CAPTION>
FISCAL YEAR ENDED FEBRUARY 28, FEBRUARY 28,
1998 1997
HIGH LOW HIGH LOW
---- --- ---- ---
<S> <C> <C> <C> <C>
First Quarter $ 7/8 $ 1/2 $ 3/8 $ 9/32
Second Quarter 1 3/16 1 1/16 7/16 17/64
Third Quarter 15/16 3/8 1 5/16
Fourth Quarter 5/16 3/16 13/16 1/2
</TABLE>
The above quotations are believed to represent inter-dealer quotations without
retail markups, markdowns or commissions and may not represent actual
transactions. The Company believes that, although limited or sporadic quotations
exist, there may not be an established public trading market for the Company's
Common Stock.
(b) As of May 20, 1998 there were 309 record holders of the Company's Common
Stock.
(c) The Company has not paid any cash dividends on its Common Stock since its
inception and intends to retain earnings, if any, for use in its business
or for other corporate purposes.
ITEM 6 Selected Financial Data(1)
- - ------
<TABLE>
<CAPTION>
Year Ended 02/28/98 02/28/97 02/29/96 02/28/95 02/28/94
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Net Sales $3,570,379 $3,110,672 $2,747,891 $2,548,363 $2,943,553
========== ========== ========== ========== ==========
Income (Loss) Before
Extraordinary Item $ 252,047 $ 152,639 $ 155,078 $ (483,050) $ (41,543)
Extraordinary Item - - - - 130,552
---------- ---------- ---------- ---------- ----------
Net Income (Loss) $ 252,047 $ 152,639 $ 155,078 $ (483,050) $ 89,009
========== ========== ========== ========== ==========
Basic Earnings Per Share:
Before Extraordinary
Item $ 0.06 $ 0.04 $ 0.04 $(0.12) $ (0.01)
Extraordinary Item - - - - 0.03
------ ------ ------ ------ ------
Basic Earnings
Per Share $ 0.06 $ 0.04 $ 0.04 $(0.12) $ 0.02
Diluted Earnings
Per Share $ 0.05 $ 0.03 $ 0.04 $(0.12) $ 0.02
Cash Dividends None None None None None
Weighted Average
Shares - Basic 4,376,064 4,204,913 4,204,913 3,876,146 3,872,000
Weighted Average
Shares - Diluted 4,773,667 4,507,441 4,477,646 3,911,323 3,872,000
Total Assets $1,728,678 $1,251,868 $1,199,717 $1,211,161 $1,635,715
Long-Term Liabilities $ 585,898 $ 576,722 $ 668,082 $ 775,816 $ 866,084
<FN>
(1) Should be read in conjunction with the Financial Statements and notes thereto.
</FN>
</TABLE>
ITEM 7 Management's Discussion and Analysis of Financial Condition and Results
- - ------
of Operations
Forward-Looking Statements
- - --------------------------
Certain statements made in this report may constitute "forward-looking
statements" within the meaning of the Federal Securities Laws. Such
forward-looking statements include statements regarding the intent, belief or
current expectations of the Company and its management and involve known and
unknown risks, uncertainties and other factors which may cause the actual
results, performance or achievements of the Company to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements. Such factors include, among other things, the
following: general economic and business conditions; political, regulatory,
competitive and technological developments affecting the Company's operations or
the demand for its products; timely development and market acceptance of new
products; adequacy of financing; capacity additions; and ability to enforce
patents.
Capital Resources and Liquidity
- - -------------------------------
On February 28, 1998, the Company had working capital of $691,335 and a
stockholders' equity of $278,557. This compares to working capital of $419,754
and a stockholders' deficiency of $41,278 on February 29, 1997. The increase in
working capital of $271,581 and the increase of $319,835 in the Company's
stockholders' equity is primarily a result of the Company's profitable
operations during Fiscal 1998 and the restructuring of debt. On April 30, 1997
the Company reached an agreement with the holders of $530,000 of Subordinated
Convertible Notes, whereby they agreed to, among other things, accept shares of
the Company's Common Stock as payment for the total amount of interest due as of
February 28, 1997 and extend the term of the Notes until August 2000.
During Fiscal 1998 and 1997 the Company reduced its obligations on a bank loan
by $94,173 and $72,654, respectively. During Fiscal 1998 the Company obtained a
$150,000 revolving line of credit which is collateralized by accounts
receivable, inventory and all other personal property of the Company. As of May
20, 1998, the Company has used $50,000 from the line of credit.
Capital expenditures increased during Fiscal 1998 to $95,000 from $16,000 during
Fiscal 1997. The increase was mainly due to the purchase of production
equipment. During Fiscal 1998, the Company entered into a $57,000 term loan
agreement which is collateralized by a piece of production equipment.
The Company's Convertible Secured Subordinated Notes mature on August 15, 2000
and the Company may experience difficulty meeting the new due date unless the
level of profitability of the Company improves substantially or unless the
noteholders agree to future extensions of the repayment terms. There can be no
assurances that such extensions can be negotiated or that such extensions will
be on terms as favorable to the Company as those presently in effect.
During Fiscal 1998 the Company introduced a line of liquid delivery systems
which are designed to complement its line of Nozzle Systems. During Fiscal 1999
the Company intends to continue to expand into new markets by offering a full
range of spraying solutions. Although there can be no assurances, management
believes that these new products will lead to broader markets and continued
increases in sales and profits, which will in turn allow the Company to meet its
current obligations as they become due.
Results of Operations - 1998 Compared to 1997
- - ---------------------------------------------
The Company's sales increased $459,707or 15% from $3,110,672 for Fiscal 1997 to
$3,570,379 for Fiscal 1998. The increase in sales resulted from in an increase
in unit sales of the Company's SonoFlux Systems. Sales of this product increased
$747,870 or 36% from $2,062,313 in Fiscal 1997 to $2,810,182 in Fiscal 1998. The
Company attributes the increase in sales of this product to the success of its
newest generation of SonoFlux Systems the "9500". Sales of the Company's Nozzle
Systems decreased $288,161 or 27% from $1,048,357 in Fiscal 1997 to $760,197 in
Fiscal 1998.
The Company's cost of goods sold increased $221,244 or 15% from $1,518,971 in
Fiscal 1997 to $1,740,217 in Fiscal 1998. The increase in cost of goods sold is
a result of an increase in sales of the Company's products, a change in product
mix and an increase in the cost of certain purchased components of the SonoFlux
System. The gross profit margin remained constant between Fiscal 1997 and 1998.
Research and product development costs increased $40,590 or 11% from $369,133 in
Fiscal 1997 to $409,722 in Fiscal 1998. The increase is a result of additional
staff to work on new product development.
General and administrative costs increased $18,920 or 5% from $377,037 in Fiscal
1997 to $395,954 in Fiscal 1998 as a result of additional employee costs and
professional fees.
Sales and Marketing costs increased $93,625 or $15% from $630,295 in Fiscal 1997
to $723,919 in Fiscal 1998. The increase was due to commissions generated from
higher sales.
The Company's operating profit increased $85,331 or 40% from $215,236 in Fiscal
1997 to $300,567 in Fiscal 1998. The increase in operating profit is a result of
increased sales of the Company's products while keeping increases in overhead
expenses to a minimum.
Interest and other income decreased $3,823 or 91% from $4,192 in Fiscal 1997 to
$369 in Fiscal 1998. Interest expense decreased $17,901 or 27% from $66,789 in
Fiscal 1997 to $48,888 in Fiscal 1998 due to monthly installment payments
reducing the outstanding principal balances outstanding during Fiscal 1998.
During Fiscal 1999 the Company expects the bank loan will be paid in full. New
equipment that was purchased during the 4th quarter was financed and had a
negligible effect on interest expense.
Inflation and changing prices did not have a material effect on the Company's
operations in Fiscal 1998 or 1997.
Results of Operations - 1997 Compared to 1996
- - ---------------------------------------------
The Company's sales increased $362,781 or 13% from $2,747,891 for Fiscal 1996 to
$3,110,672 for Fiscal 1997. The increase in sales resulted primarily in an
increase in sales of the Company's SonoFlux Systems. Sales of this product
increased $322,854 or 19% from $1,739,459 in Fiscal 1996 to $2,062,313 in Fiscal
1997. The Company attributes the increase in sales of this product to the
success of its newest generation of SonoFlux Systems the "9500". Sales of the
Company's Nozzle Systems increased $39,925 or 4% from $1,008,432 in Fiscal 1996
to $1,048,357 in Fiscal 1997.
The Company's cost of goods sold increased $307,679 or 25% from $1,211,292 in
Fiscal 1996 to $1,518,971 in Fiscal 1997. The increase in cost of goods sold is
a result of an increase in sales of the Company's products, a change in product
mix and an increase in the cost of certain purchased components of the SonoFlux
System.
Research and product development costs decreased $10,810 or 3% from $379,942 in
Fiscal 1996 to $369,133 in Fiscal 1997. Such costs had been higher in previous
years due to prototype and consulting costs associated with the development of
the SonoFlux 9500.
General and administrative costs increased $17,895 or 5% from $359,142 in Fiscal
1996 to $377,037 in Fiscal 1997. During Fiscal 1996 the Company substantially
reduced its reserve for uncollectible accounts which resulted in significantly
lower general and administrative costs for that year.
The Company's operating profit increased $52,118 or 32% from $163,118 in Fiscal
1996 to $215,236 in Fiscal 1997. The increase in operating profit is a result of
increased sales of the Company's products while keeping increases in overhead
expenses to a minimum.
Interest and other income decreased $56,168 from $60,360 in Fiscal 1996 to
$4,192 in Fiscal 1997. During Fiscal 1996 the Company had income from joint
development work from a company involved with the manufacture of semiconductor
wafers. In addition, the Company realized income from an accounting adjustment
to certain accounts payable.
Year 2000 Compliance
- - --------------------
The Company utilizes desktop and network software for its computer information
systems. The year 2000 issue has been evaluated and procedures will be taken
over the next year to ensure that all systems are year 2000 compliant. The
estimated costs to complete this project are not expected to have a material
effect on the Company's consolidated financial statements.
ITEM 7A Quantitative and Qualitative Disclosures about Market Risk
- - -------
Not applicable
ITEM 8 Financial Statements and Supplementary Data
- - ------
Financial information required by Item 8 is included elsewhere in this report.
(See Part IV, Item 14.)
ITEM 9 Changes in and Disagreements with Accountants on Accounting and Financial
- - ------ Disclosure
(a) The Board of Directors of Sono-Tek Corporation voted to dismiss Anchin,
Block & Anchin LLP (the "Former Accountants") as the Company's independent
accountants. On October 30, 1996 the Company formally notified the former
accountants of such dismissal.
(b) There were no disagreements between the Company and the former accountants
during the Company's 1996 Fiscal and the subsequent interim period
preceding such dismissal on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure
which, if not resolved to the satisfaction of the former accountants, would
have caused the former accountants to make reference to the matter in their
reports. Additionally, during the aforesaid periods the Company was not
advised by the former accountants of any "reportable events" as defined in
paragraph 304(a)(1)(v) of regulation S-K.
(c) As required by Item 304 of Regulation S-K, the former accountants have
furnished to the Company a letter addressed to the SEC stating that they
agree with the statements made by the Company herein. A copy of this letter
is incorporated by reference in this Form 10-K as Exhibit 16.
(d) The Board of Directors of the Company, after dismissing the former
accountants as the Company's independent accountants, voted to retain
Deloitte & Touche LLP as the Company's independent accountants. The
Company's Board of Directors formally notified Deloitte & Touche LLP that
they had been retained on October 31, 1996.
PART III
ITEM 10 Directors and Executive Officers of the Registrant
- - -------
(a) Identification of Directors
<TABLE>
<CAPTION>
Name Age Position with Company
------------------------------------------------------
<S> <C> <C>
Dr. Harvey L. Berger 59 President and Director
James L. Kehoe 51 Chief Executive Officer and a Director
Samuel Schwartz 78 Chairman and a Director
J. Duncan Urquhart 44 Director
</TABLE>
Dr. Berger has been a Director of the Company since June 1975. Mr. Kehoe has
been a Director since June 1991. Mr. Schwartz has been a Director since August
1987. Mr. Urquhart has been a Director since September 1988.
The Board of Directors is divided into two classes, which were established by
the Company's shareholders at their annual meeting held on October 19, 1989. The
directors in each class serve for a term of two years, and until their
respective successors are duly elected and qualified. The terms of the classes
are staggered so that only one class of directors is elected at each annual
meeting of the Company. The terms of Messrs. Kehoe, Schwartz, and Urquhart will
be until the annual meeting to be held in 1998, and the term of Dr. Berger will
be until 1999, and in each case until their respective successors are elected
and qualified.
(b) Identification of Executive Officers
<TABLE>
<CAPTION>
Name Age Position with the Company
----------------------------------------------------------
<S> <C> <C>
Dr. Harvey L. Berger 59 President and a Director
James L. Kehoe 51 Chief Executive Officer and a Director
Kathleen N. Martin 45 Chief Financial Officer and Treasurer
Samuel Schwartz 78 Chairman and a Director
</TABLE>
Dr. Berger was Vice Chairman of the Board from March 1981 to September 1985. He
was President from November 1981 to September 1984 and again became President in
September 1985. From September 1986 to September 1988 he also served as
Treasurer. Mr. Kehoe has served as Chief Executive Officer since August 1993.
Mr. Schwartz has served as Chairman of the Board since February 1993. Ms. Martin
has served as Chief Financial Officer and Treasurer since November 1997.
The foregoing officers are elected for terms of one year or until their
successors are duly elected and qualified or until terminated by the action of
the Board of Directors. There are no arrangements or understandings between any
executive officer and any other persons(s) pursuant to which he was or is to be
selected as an officer.
(c) Family Relationships
None.
(d) Business Experience
DR. HARVEY L. BERGER has been a Director of the Company since June
1975. He was President of the Company from November 1981 to September 1984,
and has again been President of the Company since September 1985. From
September 1986 to September 1988 he also served as Treasurer. He was Vice
Chairman of the Company from March 1981 to September 1985. Dr. Berger holds
a Ph.D. in physics from Rensselaer Polytechnic Institute and is a member of
the Marist College Advisory Board.
JAMES L. KEHOE has been a Director of the Company since June, 1991 and
Chief Executive Officer of the Company since August 1993. Prior to that, he
was President and Chief Executive Officer of Plasmaco, Inc., which he
founded in 1987 and remained as President and CEO until 1993. Plasmaco is
involved in the development and manufacture of AC plasma flat panel
displays. Prior to founding Plasmaco, Mr. Kehoe was employed for twenty two
years by International Business Machines Corporation where he held a
variety of engineering and management positions.
KATHLEEN N. MARTIN has been the Chief Financial Officer and Treasurer
of the Company since November 1997. From 1992 to 1997, Ms. Martin was
employed by Plasmaco, Inc. where she served as Accounting Analyst and
Controller. Ms. Martin has a B.A. in Mathematics from Hartwick College and
a B. S. in Accounting from the State University of New York at New Paltz.
SAMUEL SCHWARTZ has been a Director of the Company since August 1987
and Chairman of the Board since February, 1993. From 1959 to 1992 he was
the Chairman and CEO of Krystinel Corporation, a manufacturer of ceramic
magnetic components used in electronic circuitry. He received a B.CH.E.
from Rensselaer Polytechnic Institute in 1941 and a M.CH.E. from New York
University in 1948.
J. DUNCAN URQUHART has been a Director of the Company since September
1988. As of October 1997, Mr. Urquhart is the Director of Business
Operations at The Gun Parts Corporation, an international supplier of gun
parts. Prior to his resignation in October 1997, he was Controller of the
Company from January 1988, and Treasurer of the Company from September
1988. He continues as a consultant to the Company.
ITEMS 11, 12, and 13
- - --------------------
The information required by Items, 11 (Executive Compensation), 12 (Security
Ownership of Certain Beneficial Owners and Management) and 13 (Certain
Relationships and Related Transactions), to the extent not incorporated by
reference from the Company's definitive proxy statement, will be contained in an
amendment to this Form 10-K which will be filed not later than 120 days after
the end of the fiscal year covered by this Form 10-K, as provided by General
Instruction G(3).
PART IV
ITEM 14 Exhibits, Financial Statement Schedules, and Reports on Form 8-K
(a)(1) The financial statements and schedules listed in the accompanying "Index
to Financial Statements" are filed as a part of this annual report.
(2) See (a)(1) above.
(3) Exhibits
Ex. No. Description
3(a)4 Certificate of Incorporation of the Company and all amendments thereto.
3(b)1 By-laws of the Company as amended.
4(a)4 Form of Convertible Note.
4(b)3 Form of Warrant.
4(c)3 Master Security Agreement.
4(d)3 Long term debt letter from The Bank of New York including Note
for $300,000.
4(e) The Company agrees to furnish a copy of the equipment loan referred to
in the Company's financial statements to the Commission upon request.
4(f)6 Form of 1995 Amendment to Convertible Note.
4(g)7 Form of 1996 Amendment to Convertible Note.
4(h)10 Form of 1997 Amendment to Convertible Note.
4(i)8 Letter agreement between the Company and The Bank of New York.
*10(a)4 Employment Agreement dated October 14, 1993 between the Company and
Dr. Harvey L. Berger.
10(b)2 Lease for the Company's facilities in Milton, NY dated July 19, 1991.
10(c)2 Amendment No. 1 to Milton, NY lease dated December 27, 1991.
10(d)4 Amendment No. 2 to Milton, NY lease dated January 22, 1992.
*10(e)5 1993 Stock Incentive Plan as amended.
169 Letter from former accountant dated October 31, 1996.
27.1 Financial Data Schedule. EDGAR filing only.
27.2 Restated Financial Data Schedule. EDGAR filing only.
* Management Contract or Compensatory Plan.
1 Incorporated herein by reference to the Company's Registration Statement on
Form S-18, File No. 33-10138NY, effective March 6, 1987.
2 Incorporated herein by reference to the Company's Form 10-K for the year
ended February 29, 1992.
3 Incorporated herein by reference to the Company's Form 10-Q Quarterly
Report of the quarter ended November 30, 1993.
4 Incorporated herein by reference to the Company's Form 10-K for the year
ended February 28, 1994.
5 Incorporated herein by reference to the Company's Form 10-Q quarterly
report for the quarter ended August 31, 1994.
6 Incorporated herein by reference to the Company's Form 10-K for the year
ended February 28, 1995.
7 Incorporated herein by reference to the Company's Form 10-K for the year
ended February 29, 1996.
8 Incorporated herein by reference to the Company's Form 10-Q quarterly
report for the quarter ended May 31, 1996.
9 Incorporated herein by reference to the Company's Form 8-K dated October
30, 1996.
10 Incorporated herein by reference to the Company's Form 10-K for the year
ended February 28, 1997.
(b) Reports on Form 8-K. No reports on Form 8-K were filed during the last
quarter of the period covered by this report.
<PAGE>
SONO-TEK CORPORATION
FORM 10-K
ITEMS 8 AND 14(d)
INDEX TO FINANCIAL STATEMENTS AND SCHEDULES
FOR THE YEAR ENDED FEBRUARY 28, 1998
INDEPENDENT AUDITORS' REPORTS - 1998 and 1997
- 1996
FINANCIAL STATEMENTS (ITEM 8):
Balance Sheets at February 28, 1998 and February 28, 1997
Statements of Income
For the Years Ended February 28, 1998, February 28, 1997
and February 29, 1996
Statements of Stockholders' Equity (Deficiency)
For the Years Ended February 28, 1998, February 28, 1997
and February 29, 1996
Statements of Cash Flows
For the Years Ended February 28, 1998, February 28, 1997
and February 29, 1996
Notes to the Financial Statements
INDEPENDENT AUDITORS' REPORT ON SUPPLEMENTAL
SCHEDULES - 1996
FINANCIAL STATEMENTS SCHEDULES (ITEM 14(d) SCHEDULES INCLUDED):
Schedule II - Valuation and Qualifying Accounts
All other schedules have been omitted because the conditions requiring
their filing do not exist or because the required information is given in
the financial statements, including the notes.
<PAGE>
INDEPENDENT AUDITORS' REPORT
To the Stockholders and Directors of
Sono-Tek Corporation
Milton, New York
We have audited the accompanying balance sheets of Sono-Tek Corporation (the
"Company") as of February 28, 1998 and 1997 and the related statements of
income, stockholders' equity (deficiency) and cash flows for the years then
ended. Our audits also included the financial statement schedules for 1998 and
1997 listed in the index at Item 14d. These financial statements and financial
statement schedules are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements and
financial statement schedules based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such 1998 and 1997 financial statements present fairly, in all
material respects, the financial position of the Company as of February 28, 1998
and 1997 and the results of its operations and its cash flows for the years then
ended in conformity with generally accepted accounting principles. Also in our
opinion, such financial statement schedules, when considered in relation to the
basic 1998 and 1997 financial statements taken as a whole, presents fairly in
all material respects, the information set forth therein.
Deloitte & Touche LLP
Hartford, CT
May 20, 1998
<PAGE>
INDEPENDENT AUDITORS' REPORT
TO THE SHAREHOLDERS AND DIRECTORS OF
SONO-TEK CORPORATION:
We have audited the accompanying statements of operations, shareholders'
equity (deficiency) and cash flows of Sono-Tek Corporation for fiscal year end
February 29, 1996. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audit.
We conducted our audit in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the results of its operations and its cash flows of
Sono-Tek Corporation for the year ended February 29, 1996 conformity with
generally accepted accounting principles.
ANCHIN, BLOCK & ANCHIN LLP
New York, New York
April 30, 1996, except for Note 5
as to which the date is May 28, 1996
<PAGE>
SONO-TEK CORPORATION
BALANCE SHEETS
ASSETS
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Current Assets
Cash and cash equivalents $113,759 $107,746
Accounts receivable (less allowance of $1,000
and $35,814 in 1998 and 1997, respectively) 810,560 525,750
Inventories - (Notes 2 and 3) 615,459 469,241
Prepaid expenses and other current assets 15,780 33,441
------ ------
Total current assets 1,555,558 1,136,178
Equipment and furnishings (less accumulated depreciation
and amortization of $369,398 and $339,829 in 1998
and 1997, respectively) (Notes 2 and 4) 122,016 56,574
Patents, patents pending and copyrights (less accumulated
amortization of $123,930 and $116,318 in 1998 and
1997, respectively) (Note 2) 45,187 52,799
Other assets 5,917 6,317
----- -----
TOTAL ASSETS $1,728,678 $1,251,868
========== ==========
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)
Current Liabilities:
Current maturities of long term debt (Note 6) $55,438 $94,370
Revolving Line of Credit (Note 5) 50,000 -
Accounts payable 405,009 267,673
Accrued expenses (Note 7) 353,776 354,381
- ------- -------
Total current liabilities 864,223 716,424
------- -------
Long term debt, less current maturities (Note 6) 577,815 576,056
Noncurrent rent payable 8,083 666
----- ---
Total liabilities 1,450,121 1,293,146
--------- ---------
Stockholders' Equity (Deficiency)
Common stock, $.01 par value; 12,000,000 shares
authorized, 4,374,387 and 4,204,913 outstanding
in 1998 and 1997, respectively 43,744 42,049
Additional paid-in capital 3,824,221 3,758,128
Accumulated deficit (3,589,408) (3,841,455)
---------- ----------
Total stockholder's equity (deficiency) 278,557 (41,278)
------- -------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $1,728,678 $1,251,868
========== ==========
</TABLE>
See notes to financial statements.
<PAGE>
SONO-TEK CORPORATION
STATEMENTS OF INCOME
<TABLE>
<CAPTION>
Years Ended
February 28, February 28, February 29,
1998 1997 1996
---- ---- ----
<S> <C> <C> <C>
Net Sales (Note 14) $3,570,379 $3,110,672 $2,747,891
Cost of Goods Sold 1,740,217 1,518,971 1,211,292
--------- --------- ---------
Gross Profit 1,830,162 1,591,701 1,536,599
--------- --------- ---------
Operating Expenses
Research and product development
costs (Note 2) 409,722 369,133 379,942
Marketing and selling expenses 723,919 630,295 634,397
General and administrative costs 395,954 377,037 359,142
------- ------- -------
Total Operating Expenses 1,529,595 1,376,465 1,373,481
--------- --------- ---------
Operating Income 300,567 215,236 163,118
Interest Expense 48,888 66,789 68,400
Interest and Other Income 369 4,192 60,360
--- ----- ------
Income Before Income Taxes 252,047 152,639 155,078
Income Tax Expense (Note 9) - - -
-------- -------- --------
Net Income $252,047 $152,639 $155,078
======== ======== ========
Basic Earnings Per Share $.06 $.04 $.04
==== ==== ====
Diluted Earnings Per Share $.05 $.03 $.04
==== ==== ====
Weighted Average Shares - Basic 4,346,064 4,204,913 4,204,913
========= ========= =========
Weighted Average Shares - Diluted 4,773,667 4,507,441 4,477,646
========= ========= =========
</TABLE>
See notes to financial statements.
<PAGE>
SONO-TEK CORPORATION
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY)
YEARS ENDED FEBRUARY 28, 1998,
FEBRUARY 28, 1997 AND FEBRUARY 29, 1996
<TABLE>
<CAPTION>
Common Stock Total
Par Value $.01 Additional Stockholders'
Paid-In Accumulated Equity
Shares Amount Capital Deficit (Deficiency)
------ ------ ------- ------- ------------
<S> <C> <C> <C> <C> <C>
Balance - February 28, 1995 4,204,913 $42,049 $3,758,128 $(4,149,172) $(348,995)
Net Income - - - 155,078 155,078
--------- ------- ---------- ----------- --------
Balance - February 29, 1996 4,204,913 42,049 3,758,128 (3,994,094) (193,917)
Net Income - - - 152,639 152,639
--------- ------- ---------- ----------- --------
Balance - February 28, 1997 4,204,913 42,049 3,758,128 (3,841,455) (41,278)
Issuance of common stock 169,474 1,695 66,093 - 67,788
Net Income - - - 252,047 252,047
--------- ------- ---------- ----------- --------
Balance - February 28, 1998 4,374,387 $43,744 $3,824,221 $(3,589,408) $278,557
========= ======= ========== =========== ========
</TABLE>
See notes to financial statements.
<PAGE>
SONO-TEK CORPORATION
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
Years Ended
February 28, February 28, February 29,
1998 1997 1996
---- ---- ----
CASH FLOWS FROM OPERATING ACTIVITIES:
<S> <C> <C> <C>
Net Income $252,047 $152,639 $155,078
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization 37,182 61,298 75,197
Provision (benefit) for doubtful accounts (34,814) 11,500 (38,000)
Loss on disposition of fixed assets and intangibles - - 13,200
(Increase) decrease in:
Accounts receivable (244,368) (75,135) (73,930)
Inventories (146,218) 8,140 13,190
Prepaid expenses and other current assets (1,131) (3,607) 14,985
Other assets 13,564 - (400)
Increase (decrease) in:
Accounts payable and accrued expenses 204,518 25,281 (60,422)
Non-current rent payable 7,417 (9,551) (11,150)
----- ------ -------
Net Cash Provided by Operating Activities 88,197 170,565 87,748
------ ------- ------
CASH FLOWS FROM INVESTING ACTIVITIES-
Purchase of equipment and furnishings (95,011) (15,634) (16,569)
------- ------- -------
CASH FLOW FROM FINANCING ACTIVITIES:
Repayment of notes and obligations payable -
professional fees - (18,472) (10,000)
Repayments of notes payable - lease termination - (23,339) (21,407)
Payments on capital leases - (1,753) (8,827)
Repayments of note payable, bank (94,173) (72,654) (54,716)
Proceeds from revolving line of credit 50,000 - -
Proceeds from equipment financing 57,000 - -
Proceeds from sale of common stock - - 25,000
------ -------- -------
Net Cash Provided by (Used in) Financing Activities 12,827 (116,218) (69,950)
------ -------- -------
NET INCREASE IN CASH AND CASH EQUIVALENTS 6,013 38,713 1,229
CASH AND CASH EQUIVALENTS
Beginning of year 107,746 69,033 67,804
------- ------ ------
End of year $113,759 $107,746 $69,033
======== ======== =======
SUPPLEMENTAL DISCLOSURE:
Interest paid $29,208 $51,419 $43,742
======= ======= =======
Non-cash exchange of accrued interest
for common stock (Note 10) $67,788 - -
======= ======= =======
</TABLE>
See notes to financial statements.
<PAGE>
SONO-TEK CORPORATION
NOTES TO FINANCIAL STATEMENTS
YEARS ENDED FEBRUARY 28, 1998, FEBRUARY 28, 1997 AND FEBRUARY 29, 1996
1. BUSINESS DESCRIPTION The Company is engaged in the development,
manufacture, and sale of ultrasonic liquid atomizing nozzle systems that
atomize low to medium viscosity liquids used in industrial spraying.
2. SIGNIFICANT ACCOUNTING POLICIES
Cash and Cash equivalents - Cash and cash equivalents consist of money
market mutual funds and short-term certificates of deposit with
original maturities of 90 days or less.
Inventories - Inventories are stated at the lower of cost or market. Cost
is determined using the first-in, first-out (FIFO) method for raw
materials, subassemblies and work-in-progress and the specific
identification method for finished goods.
Equipment and Furnishings - Equipment and furnishings are stated at cost.
Depreciation of equipment and furnishings is computed by use of the
straight-line method based on the estimated useful lives of the assets
which range from five to ten years.
Product Warranty - Expected future product warranty expense is recorded
when the product is sold.
Patent Costs and Copyrights - Costs of patent applications are deferred and
charged to operations over seventeen years for domestic patents and
twelve years for foreign patents. However, if it appears that such
costs are related to products which are not expected to be developed
for commercial application within the reasonably foreseeable future,
or are applicable to geographic areas where the Company no longer
requires patent protection, they are written-off to operations.
Copyright costs are deferred and amortized on the straight-line method
over their expected useful life of five years.
Research and Product Development Costs - Research and product development
costs represent engineering and other expenditures incurred for
developing new products, for refining the Company's existing products
and for developing systems to meet unique customer specifications for
potential orders or for new industry applications and are expensed as
incurred. Engineering costs directly applicable to the manufacture of
existing products are included in cost of goods sold.
Income Taxes - The Company accounts for income taxes under the asset and
liability method. Under this method, deferred income taxes are
recognized for the tax consequences of "temporary differences" by
applying enacted statutory tax rates applicable to future years to
differences between the financial statement carrying amounts and the
tax basis of existing assets and liabilities. If it is more likely
than not that some portion or all of a deferred tax asset will not be
realized, a valuation allowance is recognized.
Earnings Per Share - On March 3, 1997, the FASB issued SFAS No. 128
"Earnings per Share". SFAS No. 128 is effective for financial
statements issued for periods ending after December 15, 1997,
including interim periods. Earlier application was not permitted.
Restatement of all prior-period earnings per share ("EPS") data
presented is required when SFAS 128 is implemented. The Company
adopted SFAS No. 128 for the year ended February 28, 1998 and EPS data
is provided in the financial statements for all years presented based
on the requirements of this statement.
Basic EPS is computed by dividing net income by the weighted-average
number of common shares outstanding for the period. Diluted EPS
reflects the potential dilution that could occur if securities or
other contracts to issue common stock were exercised or converted into
common stock. Stock options granted but not yet exercised under the
Company's stock option plans are included for Diluted EPS calculations
under the treasury stock method. The convertible secured subordinated
promissory notes and related warrants (see Note 6) are antidilutive
and therefore are not considered for the Diluted EPS calculations.
Advertising Expenses - The Company expenses the cost of advertising in the
period in which the advertising takes place. Advertising expense for
the years ended February 28, 1998, February 28, 1997 and February 29,
1996 was $113,153, $102,439, and $94,902, respectively.
Long-Lived Assets - In March 1995, the Financial Accounting Standards Board
(FASB) issued Statement No. 121, Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed of, which
requires impairment losses for assets held and used to be recorded on
long-lived assets used in operations when indicators of impairment are
present and the undiscounted cash flows estimated to be generated by
those assets are less than the assets' carrying amount. Statement No.
121 also addresses the accounting for long-lived assets that are
expected to be disposed of. The Company adopted the Statement in the
first quarter of Fiscal 1997 and the effects of adoption were not
material.
Stock-Based Employee Compensation - The Company accounts for stock-based
compensation plans utilizing the provisions of Accounting Principles
Board Opinion No. 25 (APB 25), "Accounting for Stock Issued to
Employees". In October of 1995, the Financial Accounting Standards
Board issued Statement of Financial Accounting Standards No. 123 (SFAS
123), "Accounting for Stock-Based Compensation". The Company adopted
the provisions of SFAS 123 in Fiscal 1997. Under SFAS 123, the Company
will continue to apply the provisions of APB 25 to its stock-based
employee compensation arrangements, and is only required to supplement
its financial statements with additional proforma disclosures.
Management Estimates - The preparation of financial statements in
conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.
Reclassifications - Certain amounts in the prior year financial statements
have been reclassified to conform to the current year presentation.
3. INVENTORIES
Inventories consist of the following:
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Finished goods $173,542 $111,486
Work-in-process 160,450 110,071
Raw materials and subassemblies 281,467 247,684
------- -------
$615,459 $469,241
======== ========
</TABLE>
4. EQUIPMENT AND FURNISHINGS
Equipment and furnishings consist of the following:
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Laboratory equipment $ 77,436 $ 77,436
Machinery and equipment 89,576 196,765
Furniture and fixtures 124,402 122,202
------- -------
Totals 491,414 396,403
Less: Accumulated depreciation and
amortization 369,398 339,829
------- -------
$122,016 $ 56,574
======== ========
</TABLE>
5. REVOLVING LINE OF CREDIT
On January 2, 1998, the Company received a $150,000 line of credit which
carries an interest rate of prime plus 2% (10.5% at February 28, 1998). The
loan is collateralized by accounts receivable, inventory and all other
personal property of the Company and is payable on demand. During any
consecutive twelve month period, all outstanding advances shall be reduced
to zero for a period of 30 consecutive days. As of February 28, 1998 the
balance was $50,000. The line of credit expires June 30, 1998, at which
time the Company's financial status will be reviewed prior to an extension
being granted.
6. LONG-TERM DEBT
Long-term debt consists of the following:
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Note payable, bank, collateralized by accounts receivable, inventory,
and all other personal property of the Company. As modified in May
1996, the note is payable in monthly installments, including interest
at 2% over the bank's prime rate (10.5% at February 28, 1998), of
$7,500. The weighted average interest rate during fiscal 1998 was
10.43%. The loan has been personally guaranteed by the Company's
President and a former Chairman and Chief Executive Officer of the
Company. $46,253 $126,699
Convertible secured subordinated promissory notes with individuals,
collateralized by all of the personal property of the Company, and
subordinate to the note payable to the bank or any successor credit
facility up to $1,500,000. Payable in quarterly installments of
interest at 1/2% under the prime rate in effect on August 15 of each
year until maturity on August 15, 1997. During the fiscal years 1995
and 1996 the noteholders waived the default as to nonpayment of
interest and agreed to defer quarterly payments of interest due from
November 15, 1994 to February 15, 1997 until March 1, 1997. In April
1997, the noteholders entered into an agreement with the Company, (the
"Third Note Amendment Agreement") whereby the holders agreed to (1)
accept shares of the Company's Common Stock as payment for the total
amount of interest due as of February 15, 1997; (2) waive the default
as to nonpayment of interest until March 1, 1998; (3) extend the due
date of the note from August 15, 1997 until August 15, 2000; and (4)
reduce the interest rate from 1/2% below prime to 1% below prime. The
interest rate at February 28, 1998 was 8.25%. Each $1,000 portion of
these notes is convertible into 1,428 common shares of the Company and
a warrant, which expires in August 2000, to purchase an additional
1,428 shares of common stock at $1.50 a share. These notes include
$50,000 issued to the Company's Chairman of the Board. 530,000 530,000
Equipment loan, bank, collateralized by a piece of production
equipment, payable in monthly installments of $1,225, including
interest at 2% over the bank's prime rate (10.5% at February 28,
1998). 57,000 -
-------- --------
633,253 670,426
Due within one year 55,438 94,370
-------- --------
Due after one year $577,815 $576,056
======== ========
</TABLE>
Long-term debt is payable as follows (as of February 28, 1998):
<TABLE>
<S> <C>
February 28, 1999 $ 55,438
February 28, 2000 10,161
February 29, 2001 541,281
February 28, 2002 12,524
February 28, 2003 13,847
--------
$633,253
========
</TABLE>
Management believes the fair value of the debt payable to the bank
approximates the carrying value through the variable interest rate on the
loan. Management does not believe it is practical to determine the fair
value of the subordinated notes as there are no similar notes to compare
them to.
7. ACCRUED EXPENSES
Accrued expenses consist of the following:
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Professional fees $ 88,576 $ 83,398
Estimated warranty costs 30,250 29,994
Accrued compensation 137,068 124,532
Accrued commissions 70,480 24,380
Accrued interest 20,253 68,798
Other accrued expenses 7,149 23,279
------- -------
$353,776 $354,381
======== ========
</TABLE>
8. COMMITMENTS
Leases: The Company leased an office and manufacturing facility under a
lease that expired in January 1997. The lease provided for a five year
renewal option at annual rentals varying from $65,000 to $78,000, but that
option was not exercised. As of May 20, 1998, the Company has not signed a
renewal lease agreement. The Company is making payments on a month-to-month
basis equal to the amount that would have been required per month if the
option had been exercised.
Rent expense was approximately $73,000, $61,000, and $60,000 for the years
ended February 28, 1998, February 28, 1997, and February 29, 1996,
respectively.
9. INCOME TAXES
The annual provision for income taxes differs from amounts computed by
applying the maximum U.S. Federal income tax rate to pre-tax income as
follows:
<TABLE>
<CAPTION>
February 28, February 28, February 29,
1998 % 1997 % 1996 %
---- - ---- - ---- -
<S> <C> <C> <C> <C> <C> <C>
Computed tax at
maximum rate $85,700 34.0 $52,000 34.0 $52,700 34.0
Permanent differences 1,330 .5 - - - -
Change in valuation
allowance for tax
effect of operating
loss carry forwards (87,030) (34.5) (52,000) (34.0) (52,700) (34.4)
------ ---- ------ ---- ------ ----
Provision for
income taxes $ - - $ - - $ - -
======= ==== ======= ==== ======= ====
</TABLE>
The net deferred tax asset is comprised of the following:
<TABLE>
<CAPTION>
February 28, February 28,
1998 1997
---- ----
<S> <C> <C>
Allowance for doubtful accounts $ 0 $ 14,000
Accumulated depreciation 24,000 18,000
Accumulated amortization 8,000 9,000
Inventory 19,000 7,000
Noncurrent rent payable 3,000 1,000
Accrued vacation 11,000 13,000
Accrued expenses 57,000 74,000
Operating loss carryforwards 1,283,000 1,382,000
--------- ---------
Net deferred tax assets before valuation 1,405,000 1,528,000
Deferred tax asset valuation allowance (1,405,000) (1,528,000)
---------- ----------
Net Deferred Tax Asset $ - $ -
========== ==========
</TABLE>
The change in the valuation allowance was ($123,000), ($10,000), and
($118,000) for the years ended February 28, 1998, February 28, 1997 and
February 29, 1996, respectively.
At February 28, 1998, the Company has available operating loss
carryforwards of approximately $3,208,000 for income tax purposes which
expire as follows:
<TABLE>
<S> <C>
2001 $129,000
2002 231,000
2003 301,000
2004 600,000
2005 to 2010 1,947,000
---------
$3,208,000
==========
</TABLE>
10. CAPITAL STOCK
On April 30, 1997, the Company reached an agreement with the holders of
$530,000 of secured convertible subordinated notes, whereby they agreed to,
among other things, accept 169,474 shares of the Company's Common Stock as
payment for the total amount of interest due as of February 28, 1997 of
$67,788.
11. STOCK OPTIONS
Under the Company's 1983 Incentive Stock Option Plan, ("1983 Plan") which
expired in May 1993, options could be granted to officers and key employees
to purchase up to 1,000,000 of the Company's common shares at not less than
fair market value at the date of grant. In March 1990, the Company filed a
registration statement with the Securities and Exchange Commission to allow
for the public resale of exercised options. Options to purchase 167,510
shares at $2 to $3.63 per share were outstanding at February 28, 1995
including options as to 151,000 shares which were exercisable, with the
balance generally becoming exercisable in cumulative installments over the
remainder of their ten year terms. During Fiscal 1996, the outstanding
options under the 1983 Plan were canceled.
Under the 1993 Stock Incentive Plan, ("1993 Plan") options can be granted
to officers, directors, consultants and employees to purchase up to 750,000
of the Company's common shares. Options granted under the 1993 Plan expire
on various dates through 2003.
Under the 1993 Stock Incentive Plan, option prices must be at least 100% of
the fair market value of the common stock at time of grant. For qualified
employees, except under certain circumstances specified in the 1993 plan or
unless otherwise specified at the discretion of the Board of Directors, no
option may be exercised prior to one year after date of grant, with the
balance becoming exercisable in cumulative installments over a three year
period during the term of the option, and terminate at a stipulated period
of time after an employee's termination of employment.
During Fiscal 1998, the Company granted options for 299,000 shares
exercisable at between $.37 per share and $.82 per share to qualified
employees. During Fiscal 1997, the Company granted to qualified employees
17,500 shares exercisable at $.78 per share and 5,124 shares, exercisable
at $.625 per share to outside consultants. In Fiscal 1996, the Company
granted to qualified employees 52,500 shares exercisable at $.33 per share.
A summary of the 1993 Plan activity for the three year period ended
February 28, 1998 is as follows:
<TABLE>
<CAPTION>
Weighted Average
Stock Options Exercise Price
Outstanding Exercisable Outstanding Exercisable
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Balance - February 28, 1995 291,000 50,000 $ .38 $ .38
Granted - Fiscal 1996 52,500 .33
Canceled - Fiscal 1996 (60,000) (.38)
------- ------- ---- ----
Balance - February 29, 1996 283,500 131,450 .37 .37
Granted - Fiscal 1997 22,624 .74
Canceled - Fiscal 1997 (2,500) (.38)
------- ------- ---- ----
Balance - February 28, 1997 303,624 221,544 .40 .35
Granted Fiscal 1998 299,000 .42
Canceled Fiscal 1998 (45,000) (.52)
------- ------- ---- ----
Balance - February 28, 1998 557,627 457,875 $ .40 $ .38
======= ======= ===== =====
</TABLE>
The fair value of options granted under the Company's fixed stock option
plans during Fiscal 1998, 1997 and 1996 were estimated on the dates of
grant using the Black-Scholes options-pricing models with the following
weighted-average assumptions used: expected volatility of approximately 75%
(60% in Fiscal 1997 and 1996), risk free interest rate of approximately 6%
(6.3% in Fiscal 1997 and 1996), and expected lives of option grants of
approximately five years. The effects of applying SFAS 123 in this pro
forma disclosure are not indicative of future pro forma effects.
The estimated fair value of options granted during Fiscal 1998, 1997 and
1996 were $.17 per share, $.20 per share and $.09 per share, respectively.
The Company applies Accounting Principles Board Opinion No. 25 and related
interpretations in accounting for the 1993 Plan. Had compensation cost for
the Company's stock option plan been determined based on the fair value at
the option grant dates for awards in accordance with the accounting
provisions of SFAS 123, the Company's net income and basic and diluted
earnings per share for the years ended February 28, 1998 and 1997 and
February 29, 1996 would have been reduced to the pro forma amounts
indicated below:
<TABLE>
<CAPTION>
1998 1997 1996
---- ---- ----
<S> <C> <C> <C>
Net income:
As reported $252,047 $152,639 $155,078
Pro forma $210,896 $147,229 $153,034
Basic earnings per share:
As reported $ .06 $ .04 $ .04
Pro forma $ .05 $ .04 $ .04
Diluted earnings per share:
As reported $ .05 $ .03 $ .04
Pro forma $ .04 $ .03 $ .03
</TABLE>
12. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted
earnings per share:
<TABLE>
<CAPTION>
February 28, February 28, February 29,
1998 1997 1996
---- ---- ----
<S> <C> <C> <C>
Numerator-
Numerator for basic and diluted earnings
per share - net income $252,047 $152,639 $155,078
======== ======== ========
Denominator:
Denominator for basic earnings per share -
weighted average shares 4,346,064 4,204,913 4,204,913
Effects of dilutive securities:
Stock options for employees
and outside consultants 427,603 302,528 272,733
--------- --------- ---------
Denominator for diluted earnings per share 4,773,667* 4,507,441* 4,477,646*
========= ========= =========
Basic Earnings Per Share $.06 $.04 $.04
==== ==== ====
Diluted Earnings Per Share $.05 $.03 $.04
==== ==== ====
</TABLE>
*The effect of considering the convertible secured subordinated promissory
notes and related warrants (see Note 6) are antidilutive and therefore not
considered for the diluted earnings per share calculations.
13. RELATED PARTY TRANSACTIONS
During Fiscal 1996 the Company incurred $26,000 in consulting fees to its
Chairman of the Board under an agreement commencing March 1993. At February
28, 1998 and February 28, 1997, accounts payable includes a liability for
these and prior year fees of $69,076.
14. SIGNIFICANT CUSTOMERS AND FOREIGN SALES
No single customer accounted for more than 10% of sales for the years ended
February 28, 1998, February 28, 1997 and February 29, 1996.
Export sales to customers located outside the United States were
approximately as follows:
<TABLE>
<CAPTION>
February 28, February 28, February 29,
1998 1997 1996
---- ---- ----
<S> <C> <C> <C>
Western Europe $ 41,000 $399,000 $269,000
Far East 163,000 164,000 146,000
Other 231,000 116,000 329,000
------- ------- -------
$435,000 $679,000 $744,000
======== ======== ========
</TABLE>
<PAGE>
INDEPENDENT AUDITORS' REPORT
ON
SUPPLEMENTAL SCHEDULES
TO THE SHAREHOLDERS AND DIRECTORS OF
SONO-TEK CORPORATION:
In connection with our audit of the financial statements of Sono-Tek
Corporation for the year ended February 29, 1996, we also audited Schedule II
for the year ended February 29, 1996, included in the annual report of Sono-Tek
Corporation of Form 10-K for the year ended February 28, 1998. In our opinion,
the schedule presents fairly the information required to be set forth therein.
ANCHIN, BLOCK & ANCHIN LLP
New York, New York
April 30, 1996
<PAGE>
SCHEDULE II
SONO-TEK CORPORATION
VALUATION AND QUALIFYING ACCOUNTS
<TABLE>
<CAPTION>
Column C
Column A Column B Additions Column D Column E
Balance Charged (credited) Charged to Balance
at Beginning to Costs and to Other at End
Description of Period Expenses Accounts Deductions* of Period
- - ----------- --------- -------- -------- ----------- ---------
<S> <C> <C> <C> <C> <C>
Allowance for doubtful accounts:
Year Ended February 28, 1998 $35,814 ($34,814) - $ 0 $1,000
Year Ended February 28, 1997 25,000 11,500 - 686 35,814
Year Ended February 29, 1996 63,000 (37,596) - 404 25,000
</TABLE>
* Represents write-off net of recovery, of uncollectible accounts
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereto duly authorized.
Dated: May 29, 1998
Sono-Tek Corporation
(Registrant)
By: /s/ James L. Kehoe
------------------
James L. Kehoe
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the dates indicated.
/s/ Samuel Schwartz May 29, 1998
- - -------------------
Samuel Schwartz
Chairman of the Board
/s/ James L. Kehoe May 29,1998
- - ------------------
James L. Kehoe
Chief Executive Officer
and Director
/s/ Harvey L. Berger May 29, 1998
- - --------------------
Harvey L. Berger
President and Director
/s/ J. Duncan Urquhart May 29, 1998
- - ----------------------
J. Duncan Urquhart
Director
/s/ Kathleen N. Martin May 29, 1998
- - ----------------------
Kathleen N. Martin
Treasurer and Chief Financial Officer
<PAGE>
EXHIBIT INDEX
Ex. No. Description Page
27.1 Financial Data Schedule Fiscal Year End February 28, 1998 -
EDGAR filing only
27.2 Restated Financial Data Schedules - EDGAR filing only
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000806172
<NAME> Sono-Tek Corporation
<MULTIPLIER> 1
<CURRENCY> US dollars
<S> <C>
<PERIOD-TYPE> Year
<FISCAL-YEAR-END> FEB-28-1998
<PERIOD-START> MAR-01-1997
<PERIOD-END> FEB-28-1998
<EXCHANGE-RATE> 1
<CASH> 113,759
<SECURITIES> 0
<RECEIVABLES> 810,560
<ALLOWANCES> 1,000
<INVENTORY> 615,459
<CURRENT-ASSETS> 1,555,558
<PP&E> 122,016
<DEPRECIATION> 369,398
<TOTAL-ASSETS> 1,728,678
<CURRENT-LIABILITIES> 864,223
<BONDS> 0
0
0
<COMMON> 43,744
<OTHER-SE> 234,813
<TOTAL-LIABILITY-AND-EQUITY> 1,728,678
<SALES> 3,570,379
<TOTAL-REVENUES> 3,570,379
<CGS> 1,740,217
<TOTAL-COSTS> 1,740,217
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 48,888
<INCOME-PRETAX> 252,047
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 252,047
<EPS-PRIMARY> .06
<EPS-DILUTED> .05
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND> This schedule contains summary financial
information extracted from the November 30, 1997
10Q and the February 28, 1997 10K
</LEGEND>
<CIK> 0000806172
<NAME> Sono-Tek Corporation
<MULTIPLIER> 1
<CURRENCY> US dollars
<S> <C> <C>
<PERIOD-TYPE> 9-MOS YEAR
<FISCAL-YEAR-END> FEB-28-1998 FEB-28-1997
<PERIOD-START> SEP-01-1997 MAR-01-1996
<PERIOD-END> NOV-30-1997 FEB-28-1997
<EXCHANGE-RATE> 1 1
<CASH> 21,004 107,746
<SECURITIES> 0 0
<RECEIVABLES> 677,880 525,750
<ALLOWANCES> 44,814 35,814
<INVENTORY> 515,619 469,241
<CURRENT-ASSETS> 1,232,927 1,136,178
<PP&E> 46,406 56,574
<DEPRECIATION> 360,325 339,829
<TOTAL-ASSETS> 1,333,778 1,251,868
<CURRENT-LIABILITIES> 613,172 716,424
<BONDS> 0 0
0 0
0 0
<COMMON> 43,744 42,049
<OTHER-SE> 140,202 (83,327)
<TOTAL-LIABILITY-AND-EQUITY> 1,333,778 1,251,868
<SALES> 2,588,626 3,110,672
<TOTAL-REVENUES> 2,588,626 3,110,672
<CGS> 1,270,194 1,518,971
<TOTAL-COSTS> 1,270,194 1,518,971
<OTHER-EXPENSES> 0 0
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 37,164 66,789
<INCOME-PRETAX> 157,436 152,639
<INCOME-TAX> 0 0
<INCOME-CONTINUING> 157,436 152,639
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 157,436 152,639
<EPS-PRIMARY> .04 .04
<EPS-DILUTED> .03 .03
</TABLE>
